We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03644550
Brief Title: Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma

First Submitted : August 22, 2018
First Submitted that Met QC Criteria : August 22, 2018
First Posted : August 23, 2018

Results First Submitted : October 13, 2021
Results First Posted with QC Comments : November 3, 2021
Results First Submitted that Met QC Criteria : November 3, 2021
Results First Posted : December 2, 2021

Last Update Submitted that Met QC Criteria : November 3, 2021
Last Update Posted : December 2, 2021